Viewing Study NCT00823069


Ignite Creation Date: 2025-12-24 @ 11:06 PM
Ignite Modification Date: 2025-12-25 @ 8:38 PM
Study NCT ID: NCT00823069
Status: COMPLETED
Last Update Posted: 2010-11-30
First Post: 2009-01-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
Sponsor: Medicis Global Service Corporation
Organization:

Study Overview

Official Title: A Randomized, Double-Blind Study Comparing Safety and Tolerability of PerlaneĀ® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds
Status: COMPLETED
Status Verified Date: 2010-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Safety study that compares Perlane to Perlane with Lidocaine while correcting wrinkles in the area around your nose.
Detailed Description: This is a split-face design. All 60 subjects receive Perlane on one side of their face, and Perlane-L on the other. Subjects and the investigator is blinded to which side of face receives which product. These are one time injections.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: